Elevated Expression of CAV1 is Associated with Unfavorable Prognosis of Patients with Breast Cancer Who Undergo Surgery and Neoadjuvant Chemotherapy

INTRODUCTION: Neoadjuvant chemotherapy (NACT), which is standard treatment for locally advanced breast cancer, improves the resectability of patients with early breast cancer and reduces the extent of breast and axillary surgery. Caveolin-1 (CAV1) is implicated in human cancers, although its utility...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Jia-Hui, Shi, Jia-Jun, Yin, Xi, Wu, Hong-Yan, Xu, Xin-Yun, Yao, Yong-Zhong, Zhang, Wei-Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519866/
https://www.ncbi.nlm.nih.gov/pubmed/33061584
http://dx.doi.org/10.2147/CMAR.S264673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519866/
https://www.ncbi.nlm.nih.gov/pubmed/33061584
http://dx.doi.org/10.2147/CMAR.S264673

Ejemplares similares